Global Pharmaceuticals & Biotech Most Popular Stocks

TRANSNATIONAL CANNABIS

Market Cap: US$492.0

Through its subsidiaries, engages in the cannabis business in Canada and internationally.

Calithera Biosciences

Market Cap: US$487.0

Operates under a plan of liquidation that was approved in January 2023.

Abattis Bioceuticals

Market Cap: US$476.0

Operates as a life sciences and biotechnology company in Canada.

Flower One Holdings

Market Cap: US$473.0

Engages in the cultivation and production of medical and recreational cannabis.

Choom Holdings

Market Cap: US$466.0

Engages in the retail of cannabis.

Radiko Holdings

Market Cap: US$459.0

Focuses on cannabis industries in the United States and internationally.

Flowr

Market Cap: US$426.0

The Flowr Corporation cultivates, produces, and sells cannabis in Canada.

Cannabis Strategic Ventures

Market Cap: US$404.0

Engages in the cultivation of marijuana products in the United States.

Sproutly Canada

Market Cap: US$379.0

Produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumables markets in Canada.

Eloxx Pharmaceuticals

Market Cap: US$330.0

A clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases.

Nabriva Therapeutics

Market Cap: US$323.0

A biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections.

YourWay Cannabis Brands

Market Cap: US$272.0

Through its subsidiaries, engages in the manufacture, possession, use, sale, and distribution of cannabis in the recreational and medicinal cannabis market in the United States.

Spencer Pharmaceutical

Market Cap: US$271.0

Develops drug platform technologies for the treatment of neurological deceases.

Biostar Pharmaceuticals

Market Cap: US$263.0

Develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People’s Republic of China.

Nanobac Pharmaceuticals

Market Cap: US$249.0

Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs).

Green Growth Brands

Market Cap: US$238.0

Engages in the cultivation, processing, production, distribution, and retailing of cannabis and cannabidiol (CBD)-infused consumer products in the United States.

Wayland Group

Market Cap: US$237.0

Produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally.

Khiron Life Sciences

Market Cap: US$232.0

Operates as an integrated medical and cannabis company in Latin America and Europe.

BC Craft Supply

Market Cap: US$227.0

Engages in development and acquisition of nutritional product formulae and cannabinoid brands.

Fresh2 Group

Market Cap: US$222.0

A biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People’s Republic of China.

CanaFarma Hemp Products

Market Cap: US$218.0

Engages in growing, manufacturing, processing, and selling hemp oil in the United States.

Fiore Cannabis

Market Cap: US$197.0

Fiore Cannabis Ltd. cultivates, produces, and distributes medical and recreational marijuana in the United States.

Isracann Biosciences

Market Cap: US$176.0

Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel.

Lucy Scientific Discovery

Market Cap: US$176.0

An early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products.

THC Biomed Intl

Market Cap: US$163.0

Produces and sells medical and recreational cannabis in Canada.

Pure Global Cannabis

Market Cap: US$163.0

Produces cannabis products for the medical and adult-use markets in Canada.

InNexus Biotechnology

Market Cap: US$154.0

A development stage company, engages in the commercialization of monoclonal antibodies based on its Dynamic Cross Linking (DXL) technology.

Immage Biotherapeutics

Market Cap: US$151.0

Does not have significant business operations.

Halo Collective

Market Cap: US$150.0

Engages in the cultivation, manufacture, transportation, and distribution of cannabis and cannabis extracts in Canada and the United States.

Poniard Pharmaceuticals

Market Cap: US$149.0

A biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics.

Q BioMed

Market Cap: US$145.0

A biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies.

CannTrust Holdings

Market Cap: US$141.0

Produces and distributes medical and recreational cannabis in Canada.

Eden Empire

Market Cap: US$137.0

Invests in and operates in the cannabis sector.

Seelos Therapeutics

Market Cap: US$136.0

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system and other disorders.

PsyBio Therapeutics

Market Cap: US$132.0

A biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States.

Marizyme

Market Cap: US$131.0

A multi-technology life science company, engages in the research, manufacture, and commercialization of medical devices, diagnostics, and products to address clinical needs in the United States, Europe, and Asia.